These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37114324)

  • 1. Aptamer-based technology for gastric cancer theranostics.
    Lv QY; Cui HF; Song X
    Anal Methods; 2023 May; 15(18):2142-2153. PubMed ID: 37114324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cell-based single-stranded DNA aptamer specifically targets gastric cancer.
    Zhang X; Zhang J; Ma Y; Pei X; Liu Q; Lu B; Jin L; Wang J; Liu J
    Int J Biochem Cell Biol; 2014 Jan; 46():1-8. PubMed ID: 24501772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of a gastric carcinoma cell-specific DNA aptamer by live cell-SELEX.
    Cao HY; Yuan AH; Shi XS; Chen W; Miao Y
    Oncol Rep; 2014 Nov; 32(5):2054-60. PubMed ID: 25175855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamer-Programmed DNA Nanodevices for Advanced, Targeted Cancer Theranostics.
    Walia S; Chandrasekaran AR; Chakraborty B; Bhatia D
    ACS Appl Bio Mater; 2021 Jul; 4(7):5392-5404. PubMed ID: 35006722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A DNA aptamer with high affinity and specificity for molecular recognition and targeting therapy of gastric cancer.
    Cao HY; Yuan AH; Chen W; Shi XS; Miao Y
    BMC Cancer; 2014 Sep; 14():699. PubMed ID: 25248985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamer Selection for Detecting Molecular Target Using Cell-SELEX (Systematic Evolution of Ligands by Exponential Enrichment) Technology.
    Stewart KD; Tan W; Park JY
    Methods Mol Biol; 2019; 2054():223-241. PubMed ID: 31482459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamer-Based Tumor-Targeted Diagnosis and Drug Delivery.
    Woldekidan HB; Woldesemayat AA; Adam G; Tafesse M; Thimiri Govinda Raj DB
    Adv Exp Med Biol; 2023; 1409():173-192. PubMed ID: 35896892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic applications of gastric carcinoma cell aptamers in vitro and in vivo.
    Ding F; Guo S; Xie M; Luo W; Yuan C; Huang W; Zhou Y; Zhang XL; Zhou X
    Talanta; 2015 Mar; 134():30-36. PubMed ID: 25618637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamers: a novel targeted theranostic platform for pancreatic ductal adenocarcinoma.
    Li Q; Maier SH; Li P; Peterhansl J; Belka C; Mayerle J; Mahajan UM
    Radiat Oncol; 2020 Aug; 15(1):189. PubMed ID: 32758252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamers in hematological malignancies and their potential therapeutic implications.
    Ouyang W; Yu Z; Zhao X; Lu S; Wang Z
    Crit Rev Oncol Hematol; 2016 Oct; 106():108-17. PubMed ID: 27637356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of RNA aptamer-based therapeutic agents.
    Li Y; Wu H; Niu Y; Hu Y; Li Q; Cao C; Cai J
    Curr Med Chem; 2013; 20(29):3655-63. PubMed ID: 23745560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generating aptamers by cell-SELEX for applications in molecular medicine.
    Ye M; Hu J; Peng M; Liu J; Liu J; Liu H; Zhao X; Tan W
    Int J Mol Sci; 2012; 13(3):3341-3353. PubMed ID: 22489154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamer-targeted oligonucleotide theranostics: a smarter approach for brain delivery and the treatment of neurological diseases.
    Sriramoju B; Kanwar R; Veedu RN; Kanwar JR
    Curr Top Med Chem; 2015; 15(12):1115-24. PubMed ID: 25866271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
    Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamer Technology and Its Applications in Bone Diseases.
    Liu X; Hu J; Ning Y; Xu H; Cai H; Yang A; Shi Z; Li Z
    Cell Transplant; 2023; 32():9636897221144949. PubMed ID: 36591965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial to the IJMS Special Issue "Aptamer-Mediated Cancer Theranostics".
    Danquah MK
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of aptamers in prostate cancer: A systematic review of theranostic applications.
    Campos-Fernández E; Oliveira Alqualo N; Moura Garcia LC; Coutinho Horácio Alves C; Ferreira Arantes Vieira TD; Caixeta Moreira D; Alonso-Goulart V
    Clin Biochem; 2021 Jul; 93():9-25. PubMed ID: 33794195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamer-based biosensors and application in tumor theranostics.
    Mo T; Liu X; Luo Y; Zhong L; Zhang Z; Li T; Gan L; Liu X; Li L; Wang H; Sun X; Fan D; Qian Z; Wu P; Chen X
    Cancer Sci; 2022 Jan; 113(1):7-16. PubMed ID: 34747552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Highlight of Recent Advances in Aptamer Technology and Its Application.
    Sun H; Zu Y
    Molecules; 2015 Jun; 20(7):11959-80. PubMed ID: 26133761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamers used for molecular imaging and theranostics - recent developments.
    Bohrmann L; Burghardt T; Haynes C; Saatchi K; Häfeli UO
    Theranostics; 2022; 12(9):4010-4050. PubMed ID: 35673581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.